SELLAS Life Sciences Group Inc. Common Stock vs Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.24 (market cap $2.28B), while Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) trades at $24.85 (market cap $160.34B). The key difference: Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) is far larger — about 70.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) pays a 2.33% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | SMFG | |
|---|---|---|
Market Cap | $2.28B | $160.34B |
Volume | 3,128,960 | 2,067,536 |
Sector | Health | Financials |
52-Week High | $15.46 | $27.56 |
52-Week Low | $1.39 | $15.20 |
Enterprise Value | $2.15B | $12.79T |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 2.33% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →Sumitomo Mitsui Financial Group is a Japanese financial services company with banking, securities, leasing, and asset management businesses. It serves retail, corporate, and institutional clients.
Read more on SMFG →